Delivery Order SPE2DB22D3019-SPE2DB25FK4EA
- Not listed
- The Defense Logistics Agency awarded a $1,476.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhalers (10.7GM) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $5,655.28 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Airsupra 90-80 microgram inhaler in 10.7-gram units. This firm fixed price, non-set-aside contract is scheduled for completion by August 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,894.52 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Airsupra 90-80 micrograms inhaler in 10.7-gram units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Airsupra 90-80 mcg inhalers (10.7 gm units) with a ceiling value of $2,627.78. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. As a child contract, this order draws from AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,328.03 firm fixed price delivery order for AIRSUPRA 90-80 MCG Inhaler 10.7GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive contract will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,584.23 on September 17, 2025, for the supply of Airsupra 90-80 micrograms inhaler in 10.7-gram units. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through...
- The Defense Logistics Agency awarded a $2,762.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Airsupra 90-80 microgram inhaler (10.7 grams) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside competitive award is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,734.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Airsupra 90-80 microgram inhalers (10.7 grams). This is a non-set-aside competitive award with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.00 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,062.30 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM on April 21, 2025, with completion targeted for April 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4EADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,808.52 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Airsupra 90-80 microgram inhaler units (10.7 grams). This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of September 4, 2025. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. The company's extensive contract portfolio with DLA reflects its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains through open competition. This delivery order for respiratory medication supports the broader Defense Health Agency mission of ensuring adequate medical supply availability for military personnel and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.8k | 9/3/25 |